The invention relates to an oral pharmaceutical composition comprising, greater than 80% of Imatinib, by weight based on the total weight of the composition and the process for preparation thereof.Linvention concerne une composition pharmaceutique orale comprenant plus de 80% en poids dimatinib sur la base du poids total de la composition et son procédé de préparation.
